Status:
UNKNOWN
Prediction of Chemotherapy Toxicity and Survival in Elderly Cancer Patients by CARG Score
Lead Sponsor:
Assiut University
Conditions:
Solid Tumors ,Adults
Eligibility:
All Genders
65+ years
Brief Summary
Prediction of chemotherapy toxicity and survival in elderly (aged ≥65 years old) patients with advanced solid tumors receiving systemic chemotherapy by using CARG risk score.
Detailed Description
Elderly patients (age ≥65 years) with cancer represent a growing proportion of patients in oncology clinical practice, primarily due to increasing life-spans as well as medical progress contributing t...
Eligibility Criteria
Inclusion
- Age: ≥65 years.
- Sex: male, female.
- ECOG performance status 0,1,2
- Type of malignancy: solid tumor malignancies planned for systemic chemotherapy alone.
- Stage: Advanced stage (metastatic first line, recurrent, unresectable locally advanced).
- Type of Systemic therapy: chemotherapy alone not combined with immunotherapy or radiotherapy.
- Able to comprehend and complete questionnaire.
Exclusion
- Receiving concurrent radiotherapy or immunotherapy.
- ECOG performance status \>2.
Key Trial Info
Start Date :
July 20 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2025
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT05432726
Start Date
July 20 2022
End Date
July 1 2025
Last Update
July 19 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.